<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37745259</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>26</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2220-3141</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>09</Day></PubDate></JournalIssue><Title>World journal of critical care medicine</Title><ISOAbbreviation>World J Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Delayed inflammatory pulmonary syndrome: A distinct clinical entity in the spectrum of inflammatory syndromes in COVID-19 infection?</ArticleTitle><Pagination><StartPage>226</StartPage><EndPage>235</EndPage><MedlinePgn>226-235</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.5492/wjccm.v12.i4.226</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">During the second wave of the coronavirus disease 2019 (COVID-19) pandemic, a subset of critically ill patients developed delayed respiratory deterioration in the absence of new infection, fluid overload or extra-pulmonary organ dysfunction.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To describe the clinical and laboratory characteristics, outcomes, and management of these patients, and to contrast this entity with other post COVID-19 immune dysregulation related inflammatory disorders.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective observational study of adult patients admitted to the medical intensive care unit of a 2200-bed university affiliated teaching hospital, between May and August 2021, who fulfilled clearly defined inclusion and exclusion criteria. Outcome was assessed by a change in PaO<sub>2</sub>/FiO<sub>2</sub> ratio and levels of inflammatory markers before and after immunomodulation, duration of mechanical ventilation after starting treatment, and survival to discharge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Five patients developed delayed respiratory deterioration in the absence of new infection, fluid overload or extra-pulmonary organ dysfunction at a median interquartile range (IQR) duration of 32 (23-35) d after the onset of symptoms. These patients had elevated inflammatory markers, required mechanical ventilation for 13 (IQR 10-23) d, and responded to glucocorticoids and/or intravenous immunoglobulin. One patient died (20%).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This delayed respiratory worsening with elevated inflammatory markers and clinical response to immunomodulation appears to contrast the well described Multisystem Inflammatory Syndrome - Adults by the paucity of extrapulmonary organ involvement. The diagnosis can be considered in patients presenting with delayed respiratory worsening, that is not attributable to cardiac dysfunction, fluid overload or ongoing infections, and associated with an increase in systemic inflammatory markers like C-reactive protein, inteleukin-6 and ferritin. A good response to immunomodulation can be expected. This delayed inflammatory pulmonary syndrome may represent a distinct clinical entity in the spectrum of inflammatory syndromes in COVID-19 infection.</AbstractText><CopyrightInformation>&#xa9;The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bose</LastName><ForeName>Prithviraj</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medical Intensive Care, Christian Medical College, Vellore 632004, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chacko</LastName><ForeName>Binila</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medical Intensive Care, Christian Medical College, Vellore 632004, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arul</LastName><ForeName>Ashwin Oliver</ForeName><Initials>AO</Initials><AffiliationInfo><Affiliation>Department of Medical Intensive Care, Christian Medical College, Vellore 632004, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson Vimala</LastName><ForeName>Leena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiodiagnosis, Christian Medical College, Vellore 632004, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thangakunam</LastName><ForeName>Balamugesh</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Christian Medical College, Vellore 632004, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varghese</LastName><ForeName>George M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease, Christian Medical College, Vellore 632004, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jambugulam</LastName><ForeName>Mohan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Christian Medical College, Vellore 632004, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lenin</LastName><ForeName>Audrin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Christian Medical College, Vellore 632004, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peter</LastName><ForeName>John Victor</ForeName><Initials>JV</Initials><AffiliationInfo><Affiliation>Department of Medical Intensive Care, Christian Medical College, Vellore 632004, Tamil Nadu, India. peterjohnvictor@yahoo.com.au.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Crit Care Med</MedlineTA><NlmUniqueID>101622182</NlmUniqueID><ISSNLinking>2220-3141</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Multisystem Inflammatory Syndrome in Adults</Keyword><Keyword MajorTopicYN="N">Organizing pneumonia</Keyword></KeywordList><CoiStatement>Conflict-of-interest statement: There was no conflict of interest or any financial disclosure for all the authors listed in the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>25</Day><Hour>4</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37745259</ArticleId><ArticleId IdType="pmc">PMC10515099</ArticleId><ArticleId IdType="doi">10.5492/wjccm.v12.i4.226</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marini JJ, Gattinoni L. Management of COVID-19 Respiratory Distress. JAMA. 2020;323:2329&#x2013;2330.</Citation><ArticleIdList><ArticleId IdType="pubmed">32329799</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, Soma VL, Maddux AB, Mourani PM, Bowens C, Maamari M, Hall MW, Riggs BJ, Giuliano JS Jr, Singh AR, Li S, Kong M, Schuster JE, McLaughlin GE, Schwartz SP, Walker TC, Loftis LL, Hobbs CV, Halasa NB, Doymaz S, Babbitt CJ, Hume JR, Gertz SJ, Irby K, Clouser KN, Cvijanovich NZ, Bradford TT, Smith LS, Heidemann SM, Zackai SP, Wellnitz K, Nofziger RA, Horwitz SM, Carroll RW, Rowan CM, Tarquinio KM, Mack EH, Fitzgerald JC, Coates BM, Jackson AM, Young CC, Son MBF, Patel MM, Newburger JW, Randolph AG Overcoming COVID-19 Investigators. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021;325:1074&#x2013;1087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905703</ArticleId><ArticleId IdType="pubmed">33625505</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris SB, Schwartz NG, Patel P, Abbo L, Beauchamps L, Balan S, Lee EH, Paneth-Pollak R, Geevarughese A, Lash MK, Dorsinville MS, Ballen V, Eiras DP, Newton-Cheh C, Smith E, Robinson S, Stogsdill P, Lim S, Fox SE, Richardson G, Hand J, Oliver NT, Kofman A, Bryant B, Ende Z, Datta D, Belay E, Godfred-Cato S. Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection - United Kingdom and United States, March-August 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1450&#x2013;1456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7561225</ArticleId><ArticleId IdType="pubmed">33031361</ArticleId></ArticleIdList></Reference><Reference><Citation>Spalding MC, Cripps MW, Minshall CT. Ventilator-Associated Pneumonia: New Definitions. Crit Care Clin. 2017;33:277&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7127414</ArticleId><ArticleId IdType="pubmed">28284295</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardone M, Yano M, Rosenberg AS, Puig M. Lessons Learned to Date on COVID-19 Hyperinflammatory Syndrome: Considerations for Interventions to Mitigate SARS-CoV-2 Viral Infection and Detrimental Hyperinflammation. Front Immunol. 2020;11:1131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272717</ArticleId><ArticleId IdType="pubmed">32574265</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, DeCuir J, Abrams J, Campbell AP, Godfred-Cato S, Belay ED. Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults: A Systematic Review. JAMA Netw Open. 2021;4:e2126456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8459192</ArticleId><ArticleId IdType="pubmed">34550381</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng BH, Ban AY, Nik Abeed NN, Faisal M. Organising pneumonia manifesting as a late-phase complication of COVID-19. BMJ Case Rep. 2021;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8559103</ArticleId><ArticleId IdType="pubmed">34716149</ArticleId></ArticleIdList></Reference><Reference><Citation>Golbets E, Kaplan A, Shafat T, Yagel Y, Jotkowitz A, Awesat J, Barski L. Secondary organizing pneumonia after recovery of mild COVID-19 infection. J Med Virol. 2022;94:417&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8661567</ArticleId><ArticleId IdType="pubmed">34581458</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall KJ, Mukherjee B, Castanheira AM, Lam JL, Benedetti G, Mak SM, Preston R, Thillai M, Dewar A, Molyneaux PL, West AG. Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Ann Am Thorac Soc. 2021;18:799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M, Advani S, Moreira A, Zoretic S, Martinez J, Chorath K, Acosta S, Naqvi R, Burmeister-Morton F, Burmeister F, Tarriela A, Petershack M, Evans M, Hoang A, Rajasekaran K, Ahuja S. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine. 2020;26:100527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473262</ArticleId><ArticleId IdType="pubmed">32923992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan SS, Capstick T, Ahmed R, Kow CS, Mazhar F, Merchant HA, Zaidi STR. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020;14:1149&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7544968</ArticleId><ArticleId IdType="pubmed">32734777</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain M, Khurram Syed S, Fatima M, Shaukat S, Saadullah M, Alqahtani AM, Alqahtani T, Bin Emran T, Alamri AH, Barkat MQ, Wu X. Acute Respiratory Distress Syndrome and COVID-19: A Literature Review. J Inflamm Res. 2021;14:7225&#x2013;7242.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8710428</ArticleId><ArticleId IdType="pubmed">34992415</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalski JE, Kurche JS, Schwartz DA. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? Transl Res. 2022;241:13&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8452088</ArticleId><ArticleId IdType="pubmed">34547499</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobbs S, Chung JH, Leb J, Kaproth-Joslin K, Lynch DA. Practical Imaging Interpretation in Patients Suspected of Having Idiopathic Pulmonary Fibrosis: Official Recommendations from the Radiology Working Group of the Pulmonary Fibrosis Foundation. Radiol Cardiothorac Imaging. 2021;3:e200279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7977697</ArticleId><ArticleId IdType="pubmed">33778653</ArticleId></ArticleIdList></Reference><Reference><Citation>Serazin NA, Edem B, Williams SR, Ortiz JR, Kawade A, Das MK, &#x160;ubelj M, Edwards KM, Parida SK, Wartel TA, Munoz FM, Bastero P. Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition &amp; guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021;39:3028&#x2013;3036.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7843093</ArticleId><ArticleId IdType="pubmed">33583673</ArticleId></ArticleIdList></Reference><Reference><Citation>McFadyen JD, Stevens H, Peter K. The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications. Circ Res. 2020;127:571&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386875</ArticleId><ArticleId IdType="pubmed">32586214</ArticleId></ArticleIdList></Reference><Reference><Citation>Gando S, Wada T. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis. Shock. 2022;57:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662946</ArticleId><ArticleId IdType="pubmed">34172612</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Donatelli J, Henrich TJ. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions. Transl Res. 2022;241:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8588584</ArticleId><ArticleId IdType="pubmed">34780969</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>